Shin Poong Pharm.Co.Ltd. Cash Flow Conversion Efficiency
Shin Poong Pharm.Co.Ltd. cash flow conversion efficiency. Based on the latest financial reports, Shin Poong Pharm.Co.Ltd. (019170) has a cash flow conversion efficiency ratio of 0.013x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.42 Billion ≈ $2.31 Million USD) by net assets (₩270.73 Billion ≈ $183.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shin Poong Pharm.Co.Ltd. (2004–2025)
Cash flow conversion efficiency of Shin Poong Pharm.Co.Ltd. from 2004 to 2025. This chart illustrates how Shin Poong Pharm.Co.Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shin Poong Pharm.Co.Ltd. stock price for real-time trading data and today's change.
Shin Poong Pharm.Co.Ltd. Cash Flow Conversion Ratio Explained
Shin Poong Pharm.Co.Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shin Poong Pharm.Co.Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shin Poong Pharm.Co.Ltd. ranked by their cash flow conversion efficiency. Also see market cap of Shin Poong Pharm.Co.Ltd. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bangkok Land Public Company Limited
BK:BLAND-R
|
0.003x |
|
Prataap Snacks Limited
NSE:DIAMONDYD
|
0.038x |
|
Kingsway Financial Services Inc
NYSE:KFS
|
0.041x |
|
Firm Capital Mortgage Invest Corp
TO:FC
|
0.023x |
|
Galaxy Far East
TWO:6227
|
-0.045x |
|
Element 29 Resources Inc
V:ECU
|
-0.008x |
|
SOLiD Inc
KQ:050890
|
-0.030x |
|
Osung Advanced Materials Co. Ltd
KQ:052420
|
0.017x |
Annual Cash Flow Conversion Efficiency for Shin Poong Pharm.Co.Ltd. (2004–2025)
The table below shows the annual cash flow conversion efficiency of Shin Poong Pharm.Co.Ltd. from 2004 to 2025. Review 019170 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩270.73 Billion ≈ $183.47 Million |
₩17.25 Billion ≈ $11.69 Million |
0.064x | +208.54% |
| 2024-12-31 | ₩258.09 Billion ≈ $174.90 Million |
₩-15.15 Billion ≈ $-10.27 Million |
-0.059x | +35.91% |
| 2023-12-31 | ₩270.78 Billion ≈ $183.51 Million |
₩-24.81 Billion ≈ $-16.81 Million |
-0.092x | -14.59% |
| 2022-12-31 | ₩330.76 Billion ≈ $224.15 Million |
₩-26.44 Billion ≈ $-17.92 Million |
-0.080x | +60.09% |
| 2021-12-31 | ₩354.56 Billion ≈ $240.28 Million |
₩-71.03 Billion ≈ $-48.13 Million |
-0.200x | -473.78% |
| 2020-12-31 | ₩374.33 Billion ≈ $253.68 Million |
₩20.06 Billion ≈ $13.60 Million |
0.054x | -42.08% |
| 2019-12-31 | ₩209.13 Billion ≈ $141.72 Million |
₩19.35 Billion ≈ $13.11 Million |
0.093x | -40.11% |
| 2018-12-31 | ₩207.48 Billion ≈ $140.61 Million |
₩32.05 Billion ≈ $21.72 Million |
0.154x | +219.87% |
| 2017-12-31 | ₩210.11 Billion ≈ $142.39 Million |
₩10.15 Billion ≈ $6.88 Million |
0.048x | -44.76% |
| 2016-12-31 | ₩216.85 Billion ≈ $146.96 Million |
₩18.96 Billion ≈ $12.85 Million |
0.087x | +72.25% |
| 2015-12-31 | ₩194.86 Billion ≈ $132.05 Million |
₩9.89 Billion ≈ $6.70 Million |
0.051x | +20285.40% |
| 2014-12-31 | ₩191.51 Billion ≈ $129.79 Million |
₩-48.16 Million ≈ $-32.64K |
0.000x | -100.42% |
| 2013-12-31 | ₩190.79 Billion ≈ $129.29 Million |
₩11.45 Billion ≈ $7.76 Million |
0.060x | -63.21% |
| 2012-12-31 | ₩188.73 Billion ≈ $127.90 Million |
₩30.79 Billion ≈ $20.87 Million |
0.163x | +2.16% |
| 2011-12-31 | ₩179.86 Billion ≈ $121.89 Million |
₩28.73 Billion ≈ $19.47 Million |
0.160x | +111.50% |
| 2010-12-31 | ₩150.39 Billion ≈ $101.92 Million |
₩11.36 Billion ≈ $7.70 Million |
0.076x | +11.76% |
| 2009-12-31 | ₩145.31 Billion ≈ $98.48 Million |
₩9.82 Billion ≈ $6.65 Million |
0.068x | -63.33% |
| 2008-12-31 | ₩127.93 Billion ≈ $86.70 Million |
₩23.57 Billion ≈ $15.97 Million |
0.184x | +114.71% |
| 2007-12-31 | ₩113.81 Billion ≈ $77.12 Million |
₩9.77 Billion ≈ $6.62 Million |
0.086x | -14.81% |
| 2006-12-31 | ₩106.28 Billion ≈ $72.02 Million |
₩10.71 Billion ≈ $7.25 Million |
0.101x | +99.59% |
| 2005-12-31 | ₩97.65 Billion ≈ $66.18 Million |
₩4.93 Billion ≈ $3.34 Million |
0.050x | -57.97% |
| 2004-12-31 | ₩87.36 Billion ≈ $59.20 Million |
₩10.49 Billion ≈ $7.11 Million |
0.120x | -- |
About Shin Poong Pharm.Co.Ltd.
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial dru… Read more